http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1220818-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c079f70480165986d437742e4521e44
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24
filingDate 1967-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cccb29b35d64fb2cb0447acecb3ee5c
publicationDate 1971-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1220818-A
titleOfInvention New medicinal composition
abstract 1,220,818. Medicinal composition. MARPHA, SOC. D'ETUDE ET D'EXPLOITATION DE MARQUES. 31 Oct., 1968 [31 Oct., 1967; 24 April, 1968], Nos. 49504/67 and 19468/68. Heading A5B. A pharmaceutical composition comprises 1, 1-diphenyl-3-hexamethyleneimino - propane with a pharmaceutically acceptable water-insoluble bismuth salt. The hexamethyleneimino compound may be in the form of a salt with a cation-exchange resin.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9514483-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-597316-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0225615-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0225615-A2
priorityDate 1967-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492026
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16682734
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415748804

Total number of triples: 23.